Bogart Wealth’s Creative Medical Technology CELZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$93 Hold
100
– – ﹤0.01% 1978
2026
Q2
$145 Buy
+100
New +$216 ﹤0.01% 1920

Other funds holding CELZ

Bogart Wealth's CELZ Position: Q3 2026 in Review

Bogart Wealth held its Creative Medical Technology (CELZ) position steady in Q3 2026 at 100 shares worth $93. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

Bogart Wealth first reported a position in CELZ in Q2 2026 and has held it in 2 quarters since. The position peaked at $145 in Q2 2026. 17 funds tracked by Wall St. Rank hold CELZ as of Q3 2026.

  • Bogart Wealth held 100 shares of Creative Medical Technology worth $93 as of Q3 2026.
  • Bogart Wealth left its Creative Medical Technology share count unchanged in Q3 2026.
  • Creative Medical Technology made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1978 holding.
  • Bogart Wealth first reported a position in Creative Medical Technology in Q2 2026 and has held it in 2 quarters since.
  • Bogart Wealth's Creative Medical Technology position peaked at $145 in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Creative Medical Technology as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.